Yue-Sheng "Luke" Li

Person

Thousand Oaks, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Interleukin-2 variants and methods of uses thereof
- Patent number 12,152,060
- Issue date Nov 26, 2024
- Cugene Inc.
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
- Patent number 11,840,558
- Issue date Dec 12, 2023
- Amgen Inc.
- Edward John Belouski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stabilized receptor polypeptides and uses thereof
- Patent number 11,685,770
- Issue date Jun 27, 2023
- Amgen Inc.
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine-based bioactivatable drugs and methods of uses thereof
- Patent number 11,634,467
- Issue date Apr 25, 2023
- Cugene Inc.
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
- Patent number 11,072,640
- Issue date Jul 27, 2021
- Amgen Inc.
- Edward John Belouski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated nucleic acid molecules encoding stabilized receptor polype...
- Patent number 10,308,704
- Issue date Jun 4, 2019
- Amgen Inc.
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carrier immunoglobulins
- Patent number 10,189,912
- Issue date Jan 29, 2019
- Amgen Inc.
- Kenneth W. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating of diabetes and obesity using FGF21 mutants
- Patent number 10,011,642
- Issue date Jul 3, 2018
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carrier immunoglobulins
- Patent number 9,562,108
- Issue date Feb 7, 2017
- Amgen Inc.
- Kenneth W. Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carrier immunoglobulins
- Patent number 9,562,107
- Issue date Feb 7, 2017
- Amgen Inc.
- Kenneth W. Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 mutants comprising a mutation at position 98, 171 and/or 180
- Patent number 9,493,530
- Issue date Nov 15, 2016
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF-21 mutants comprising polyethylene glycol and uses thereof
- Patent number 9,279,013
- Issue date Mar 8, 2016
- Amgen Inc.
- Kenneth W. Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF mutants with reduced proteolysis and aggregation
- Patent number 9,273,106
- Issue date Mar 1, 2016
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized receptor polypeptides and uses thereof
- Patent number 9,273,114
- Issue date Mar 1, 2016
- Amgen Inc.
- Jeonghoon Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway...
- Patent number 8,906,371
- Issue date Dec 9, 2014
- Amgen Inc.
- Andrew A. Welcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 polypeptides comprising two or more mutations and uses thereof
- Patent number 8,835,385
- Issue date Sep 16, 2014
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF 21 polypeptides comprising two or more mutations and uses thereof
- Patent number 8,795,985
- Issue date Aug 5, 2014
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carrier immunoglobulins
- Patent number 8,734,796
- Issue date May 27, 2014
- Amgen Inc.
- Kenneth W. Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 mutant fusion polypeptides and uses thereof
- Patent number 8,642,546
- Issue date Feb 4, 2014
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 mutants multimers and uses thereof
- Patent number 8,618,053
- Issue date Dec 31, 2013
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating IFN-γ mediated diseases using human anti-IFN-γ...
- Patent number 8,529,893
- Issue date Sep 10, 2013
- Amgen Inc.
- Andrew A. Welcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 mutants and uses thereof
- Patent number 8,410,051
- Issue date Apr 2, 2013
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized activin IIB receptor polypeptides and uses thereof
- Patent number 8,410,043
- Issue date Apr 2, 2013
- Atara Biotherapeutics, Inc.
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of FGF21 polypeptides comprising two or more mutations
- Patent number 8,361,963
- Issue date Jan 29, 2013
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonists of the bradykinin B1 receptor
- Patent number 8,288,351
- Issue date Oct 16, 2012
- Amgen Inc.
- Gordon Ng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonists of the bradykinin B1 receptor
- Patent number 8,278,280
- Issue date Oct 2, 2012
- Amgen Inc.
- Gordon Ng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules that encode human anti-IFN-gamma neutralizin...
- Patent number 8,202,976
- Issue date Jun 19, 2012
- Amgen Inc.
- Andrew A. Welcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 mutants and uses thereof
- Patent number 8,188,040
- Issue date May 29, 2012
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 polypeptides comprising two or more mutations
- Patent number 8,034,770
- Issue date Oct 11, 2011
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway...
- Patent number 7,790,859
- Issue date Sep 7, 2010
- Amgen Inc.
- Andrew A. Welcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF
- Publication number 20240254185
- Publication date Aug 1, 2024
- Cugene Inc
- Yue-Sheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF
- Publication number 20240141005
- Publication date May 2, 2024
- Cugene Inc
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 Mutants and Uses Thereof
- Publication number 20240076333
- Publication date Mar 7, 2024
- Amgen Inc.
- Edward John Belouski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF
- Publication number 20240059751
- Publication date Feb 22, 2024
- Cugene Inc
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF
- Publication number 20230295267
- Publication date Sep 21, 2023
- Amgen Inc.
- Jeonghoon SUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF
- Publication number 20230093155
- Publication date Mar 23, 2023
- Cugene Inc
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF
- Publication number 20230048046
- Publication date Feb 16, 2023
- Cugene Inc
- Yue-Sheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL INTERLEUKIN-2 VARIANTS FOR THE TREATMENT OF CANCER
- Publication number 20220235109
- Publication date Jul 28, 2022
- Cugene Inc
- Yue-Sheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL INTERLEUKIN-2 VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF
- Publication number 20220170028
- Publication date Jun 2, 2022
- Cugene Inc
- Yue-Sheng Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF
- Publication number 20220106374
- Publication date Apr 7, 2022
- Cugene Inc
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FG21 MUTANTS AND USES THEREOF
- Publication number 20210317176
- Publication date Oct 14, 2021
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF
- Publication number 20210269497
- Publication date Sep 2, 2021
- Cugene Inc
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF
- Publication number 20210139553
- Publication date May 13, 2021
- Cugene Inc
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF
- Publication number 20200283504
- Publication date Sep 10, 2020
- Amgen Inc.
- Jeonghoon SUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF
- Publication number 20190389932
- Publication date Dec 26, 2019
- Amgen Inc.
- Jeonghoon SUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 Mutants and Uses Thereof
- Publication number 20190023757
- Publication date Jan 24, 2019
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARRIER IMMUNOGLOBULINS
- Publication number 20170190793
- Publication date Jul 6, 2017
- Amgen Inc.
- Kenneth W. WALKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Receptor Polypeptides and Uses Thereof
- Publication number 20170183391
- Publication date Jun 29, 2017
- Amgen Inc.
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 MUTANTS AND USES THEREOF
- Publication number 20160244497
- Publication date Aug 25, 2016
- Amgen Inc.
- Kenneth W. WALKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF MUTANTS AND USES THEREOF
- Publication number 20160168223
- Publication date Jun 16, 2016
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Receptor Polypeptides and Uses Thereof
- Publication number 20160137718
- Publication date May 19, 2016
- Amgen Inc.
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARRIER IMMUNOGLOBULINS
- Publication number 20150044235
- Publication date Feb 12, 2015
- Amgen Inc.
- Kenneth W. WALKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARRIER IMMUNOGLOBULINS
- Publication number 20150044236
- Publication date Feb 12, 2015
- Amgen Inc.
- Kenneth W. WALKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGF21 MUTANTS AND USES THEREOF
- Publication number 20140323396
- Publication date Oct 30, 2014
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 MUTANTS AND USES THEREOF
- Publication number 20140243503
- Publication date Aug 28, 2014
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma...
- Publication number 20140004127
- Publication date Jan 2, 2014
- Medarex, Inc.
- Andrew A. Welcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF
- Publication number 20130225484
- Publication date Aug 29, 2013
- Amgen
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma...
- Publication number 20120269819
- Publication date Oct 25, 2012
- Medarex, Inc.
- Andrew A. Welcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 MUTANTS AND USES THEREOF
- Publication number 20120213779
- Publication date Aug 23, 2012
- Amgen Inc.
- Edward John Belouski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARRIER IMMUNOGLOBULINS AND USES THEREOF
- Publication number 20120195879
- Publication date Aug 2, 2012
- Amgen Inc.
- Kenneth W. Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Yue-Sheng "Luke" Li

Person

Patents Grantslast 30 patents

Interleukin-2 variants and methods of uses thereof

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Stabilized receptor polypeptides and uses thereof

Cytokine-based bioactivatable drugs and methods of uses thereof

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Isolated nucleic acid molecules encoding stabilized receptor polype...

Carrier immunoglobulins

Methods of treating of diabetes and obesity using FGF21 mutants

Carrier immunoglobulins

Carrier immunoglobulins

FGF21 mutants comprising a mutation at position 98, 171 and/or 180

FGF-21 mutants comprising polyethylene glycol and uses thereof

FGF mutants with reduced proteolysis and aggregation

Stabilized receptor polypeptides and uses thereof

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway...

FGF21 polypeptides comprising two or more mutations and uses thereof

FGF 21 polypeptides comprising two or more mutations and uses thereof

Carrier immunoglobulins

FGF21 mutant fusion polypeptides and uses thereof

FGF21 mutants multimers and uses thereof

Methods for treating IFN-γ mediated diseases using human anti-IFN-γ...

FGF21 mutants and uses thereof

Stabilized activin IIB receptor polypeptides and uses thereof

Uses of FGF21 polypeptides comprising two or more mutations

Antagonists of the bradykinin B1 receptor

Antagonists of the bradykinin B1 receptor

Nucleic acid molecules that encode human anti-IFN-gamma neutralizin...

FGF21 mutants and uses thereof

FGF21 polypeptides comprising two or more mutations

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway...

Patents Applicationslast 30 patents

INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF

CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF

FGF21 Mutants and Uses Thereof

INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF

STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF

NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF

NOVEL INTERLEUKIN-2 VARIANTS FOR THE TREATMENT OF CANCER

NOVEL INTERLEUKIN-2 VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF

NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF

FG21 MUTANTS AND USES THEREOF

INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF

CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF

STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

FGF21 Mutants and Uses Thereof

CARRIER IMMUNOGLOBULINS

Stabilized Receptor Polypeptides and Uses Thereof

FGF21 MUTANTS AND USES THEREOF

FGF MUTANTS AND USES THEREOF

Stabilized Receptor Polypeptides and Uses Thereof

CARRIER IMMUNOGLOBULINS

CARRIER IMMUNOGLOBULINS

FGF21 MUTANTS AND USES THEREOF

FGF21 MUTANTS AND USES THEREOF

Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma...

STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma...

FGF21 MUTANTS AND USES THEREOF

CARRIER IMMUNOGLOBULINS AND USES THEREOF